Across TCGA pan-cancer cohorts, RPSAP64 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPSAP64’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPSAP64 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPSAP64 is over-expressed in tumor, although a few such as LIHC show the opposite, repressed pattern.

COAD, LUSC, and LIHC are the cancer types where RPSAP64 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPSAP64 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.120	.043	2	view →
LUSC	All	All	+0.142	.031	1	view →
LIHC	Female	II,III,IV	−0.079	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RPSAP64 RNA expression & survival · all RPSAP64 data types